(Q43694108)

25 November 2017

title

Repaglinide improves blood glucose control in sulphonylurea-naive type 2 diabetes (English)

1 reference

25 November 2017

1 reference

Van Gaal LF

1

1 reference

25 November 2017

Van Acker KL

series ordinal

2

1 reference

25 November 2017

De Leeuw IH

series ordinal

3

1 reference

25 November 2017

publication date

1 September 2001

1 reference

Diabetes Research and Clinical Practice

25 November 2017

published in

1 reference

25 November 2017

volume

53

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

141-148

1 reference

Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900253-4

7 January 2021

Diabetes in the elderly: diagnosis, pathogenesis, and therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900253-4

7 January 2021

Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900253-4

7 January 2021

A glimpse of the 'natural history' of established type 2 (non-insulin dependent) diabetes mellitus from the spectrum of metabolic and hormonal responses to a mixed meal at the time of diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900253-4

7 January 2021

Metabolic abnormalities in impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900253-4

7 January 2021

The clinical importance of postprandial glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900253-4

7 January 2021

The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900253-4

7 January 2021

The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900253-4

7 January 2021

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900253-4

7 January 2021

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900253-4

7 January 2021

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900253-4

7 January 2021

Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900253-4

7 January 2021

Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900253-4

7 January 2021

Insulinotropic action of meglitinide analogues: modulation by an activator of ATP-sensitive K+ channels and high extracellular K+ concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900253-4

7 January 2021

Review of prandial glucose regulation with repaglinide: a solution to the problem of hypoglycaemia in the treatment of Type 2 diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900253-4

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900253-4

7 January 2021

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900253-4

7 January 2021

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900253-4

7 January 2021

Flexible meal-related dosing with repaglinide facilitates glycemic control in therapy-naive type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900253-4

7 January 2021

Prandial glucose regulation with repaglinide: its clinical and lifestyle impact in a large cohort of patients with Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900253-4

7 January 2021

10.1016/S0168-8227(01)00253-4

Identifiers

DOI

1 reference

release_3undyrjbs5ao7jkdl3tvnuvbyu

25 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3undyrjbs5ao7jkdl3tvnuvbyu

24 November 2022

mapped directly with Wikidata item

1 reference